Kimia Farma to Offer 2.7bn New Shares via Rights Issue
Translator
Ririe Ranggasari
Editor
Petir Garda Bhwana
Kamis, 19 Agustus 2021 10:32 WIB
Kimia Farma pharmacy in Senen area, Jakarta, Monday, July 12, 2021. It is planned that the price of one dose of Kimia Farma vaccine is set at IDR 321,660 per dose, with a service price of IDR 117,910 for one injection. Tempo/Tony Hartawan
TEMPO.CO, Jakarta - State-owned pharmaceutical firm Kimia Farma (IDX: KAEF) held an extraordinary general meeting of shareholders (EGM) on Wednesday. Shareholders agreed to the company's plan of holding a rights issue, offering 2.78 billion new shares.
KAEF will issue up to 2.78 billion series B shares for Rp100 per share through a Limited Public Offering (PUT) I mechanism.
"The proceeds will be used to pay maturing loans, as working capital, and business development, including in the context of digital and IT system transformation," the management said in a statement received in Jakarta, August 19.
In the EGM, shareholders also agreed on other things including the enactment of the SOE Minister Regulation on CSR programs, changes in nomenclature, and its board of commissioners and directors overhaul.